Cite
HARVARD Citation
Tsuji, S. et al. (2014). Celecoxib, a selective cyclooxygenase‐2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritis. International journal of rheumatic diseases. pp. 44-49. [Online].